J. Scott Garland Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for J. Scott Garland.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of J. Scott Garland. J. Scott Garland is a EVP & Chief Commerical Officer in EXELIXIS, INC. ($EXEL) and a President and CEO in PORTOLA PHARMACEUTICALS INC ($PTLA) and a SVP & Chief Commercial Officer in Relypsa Inc ($RLYP) and a Director in Calithera Biosciences, Inc. ($CALA) and a Director in Karyopharm Therapeutics Inc. ($KPTI).
Address: C/O EXELIXIS, INC. 210 E. GRAND AVE SOUTH SAN FRANCISCO 94080 CA
Companies in which J. Scott Garland is an Insider
Calithera Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of J. Scott Garland: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Aug 04 2020
$CALA Market Capitalization: $187.67M
$CALA Previous Close: $9.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
EXELIXIS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of J. Scott Garland: EVP & Chief Commerical Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 19 2013
$EXEL Market Capitalization: $6.19B
$EXEL Previous Close: $20.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Karyopharm Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of J. Scott Garland: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 07 2019
$KPTI Market Capitalization: $416.55M
$KPTI Previous Close: $10.32
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PORTOLA PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of J. Scott Garland: President and CEO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 02 2020
$PTLA Market Capitalization: $1.55B
$PTLA Previous Close: $28.28
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Relypsa Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of J. Scott Garland: SVP & Chief Commercial Officer
Holdings: 18,512 shares
Latest Transaction: Sep 02 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of J. Scott Garland
Sentiment: All, CALA, EXEL, KPTI, PTLA, RLYP
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 04 2020 | CALA | Calithera Bioscien ... | Garland J. Scott | Director | Option Exercise | A | 4.70 | 40,000 | 188,000 | 40,000 | |
| Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Option Exercise | D | 0.00 | 153,399 | 0 | 0 | |
| Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Option Exercise | D | 0.00 | 370,400 | 0 | 0 | |
| Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Option Exercise | D | 12.79 | 100,000 | 1,279,000 | 0 | |
| Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Option Exercise | D | 12.79 | 200,000 | 2,558,000 | 0 | |
| Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Option Exercise | D | 0.00 | 50,000 | 0 | 0 | |
| Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Option Exercise | D | 0.00 | 100,000 | 0 | 0 |